Highbridge Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Highbridge Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$12K	–	468
2018 Q4	$12K	Hold	100,000	–	–	﹤0.01%	350
2018 Q3	$170K	Hold	100,000	–	–	﹤0.01%	454
2018 Q2	$174K	Buy	+100,000	New	+$173K	﹤0.01%	839

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Highbridge Capital Management's SGYP Position: Q1 2019 in Review

Highbridge Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 100,000 shares — an estimated $12K sold.

Highbridge Capital Management first reported a position in SGYP in Q3 2013 and held it in 9 quarters. The position peaked at $1.92M in Q4 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Highbridge Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Highbridge Capital Management sold 100,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $12K.
Highbridge Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 9 quarters.
Highbridge Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.92M in Q4 2015.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Highbridge Capital Management's 13F filing for Q1 2019, filed 15 May 2019.